BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

806 related articles for article (PubMed ID: 23354045)

  • 1. Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs.
    Kim C; Wong J; Wen J; Wang S; Wang C; Spiering S; Kan NG; Forcales S; Puri PL; Leone TC; Marine JE; Calkins H; Kelly DP; Judge DP; Chen HS
    Nature; 2013 Feb; 494(7435):105-10. PubMed ID: 23354045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maturation-Based Model of Arrhythmogenic Right Ventricular Dysplasia Using Patient-Specific Induced Pluripotent Stem Cells.
    Wen JY; Wei CY; Shah K; Wong J; Wang C; Chen HS
    Circ J; 2015; 79(7):1402-8. PubMed ID: 25971409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy.
    Ma D; Wei H; Lu J; Ho S; Zhang G; Sun X; Oh Y; Tan SH; Ng ML; Shim W; Wong P; Liew R
    Eur Heart J; 2013 Apr; 34(15):1122-33. PubMed ID: 22798562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling of arrhythmogenic right ventricular cardiomyopathy with human induced pluripotent stem cells.
    Caspi O; Huber I; Gepstein A; Arbel G; Maizels L; Boulos M; Gepstein L
    Circ Cardiovasc Genet; 2013 Dec; 6(6):557-68. PubMed ID: 24200905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of three induced pluripotent stem cell lines, SCVIi003-A, SCVIi004-A, SCVIi005-A, from patients with ARVD/C caused by heterozygous mutations in the PKP2 gene.
    Jahng JWS; Black KE; Liu L; Bae HR; Perez M; Ashley EA; Sallam K; Wu JC
    Stem Cell Res; 2021 May; 53():102284. PubMed ID: 33743362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features of arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in plakophilin-2.
    Dalal D; Molin LH; Piccini J; Tichnell C; James C; Bomma C; Prakasa K; Towbin JA; Marcus FI; Spevak PJ; Bluemke DA; Abraham T; Russell SD; Calkins H; Judge DP
    Circulation; 2006 Apr; 113(13):1641-9. PubMed ID: 16549640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penetrance of mutations in plakophilin-2 among families with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Dalal D; James C; Devanagondi R; Tichnell C; Tucker A; Prakasa K; Spevak PJ; Bluemke DA; Abraham T; Russell SD; Calkins H; Judge DP
    J Am Coll Cardiol; 2006 Oct; 48(7):1416-24. PubMed ID: 17010805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations of plakophilin-2 in Chinese with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Qiu X; Liu W; Hu D; Zhu T; Li C; Li L; Guo C; Liu X; Wang L; Zheng H; Wang C; Diao Q; Shi D; Zhan P; Deng Y; Liu K; Wang Y; Liu B; Liu H; Zhang L
    Am J Cardiol; 2009 May; 103(10):1439-44. PubMed ID: 19427443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plakophilin-2 missense mutations in arrhythmogenic right ventricular cardiomyopathy.
    Lahtinen AM; Lehtonen A; Kaartinen M; Toivonen L; Swan H; Widén E; Lehtonen E; Lehto VP; Kontula K
    Int J Cardiol; 2008 May; 126(1):92-100. PubMed ID: 17521752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of iPSC line from patient with arrhythmogenic right ventricular cardiomyopathy carrying mutations in PKP2 gene.
    Khudiakov A; Kostina D; Zlotina A; Yany N; Sergushichev A; Pervunina T; Tomilin A; Kostareva A; Malashicheva A
    Stem Cell Res; 2017 Oct; 24():85-88. PubMed ID: 29034900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deciphering the Role of Wnt and Rho Signaling Pathway in iPSC-Derived ARVC Cardiomyocytes by In Silico Mathematical Modeling.
    Parrotta EI; Procopio A; Scalise S; Esposito C; Nicoletta G; Santamaria G; De Angelis MT; Dorn T; Moretti A; Laugwitz KL; Montefusco F; Cosentino C; Cuda G
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular calcium current disorder and disease phenotype in
    Chen P; Xiao Y; Wang Y; Zheng Z; Chen L; Yang X; Li J; Wu W; Zhang S
    Theranostics; 2020; 10(24):11215-11229. PubMed ID: 33042279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of Genotype on Structural Atrial Abnormalities and Atrial Fibrillation or Flutter in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.
    Bourfiss M; Te Riele AS; Mast TP; Cramer MJ; VAN DER Heijden JF; VAN Veen TA; Loh P; Dooijes D; Hauer RN; Velthuis BK
    J Cardiovasc Electrophysiol; 2016 Dec; 27(12):1420-1428. PubMed ID: 27572111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive desmosome mutation analysis in north americans with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    den Haan AD; Tan BY; Zikusoka MN; Lladó LI; Jain R; Daly A; Tichnell C; James C; Amat-Alarcon N; Abraham T; Russell SD; Bluemke DA; Calkins H; Dalal D; Judge DP
    Circ Cardiovasc Genet; 2009 Oct; 2(5):428-35. PubMed ID: 20031617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autosomal Recessive Nonsyndromic Arrhythmogenic Right Ventricular Cardiomyopathy without Cutaneous Involvements: A Novel Mutation.
    Soveizi M; Rabbani B; Rezaei Y; Saedi S; Najafi N; Maleki M; Mahdieh N
    Ann Hum Genet; 2017 Jul; 81(4):135-140. PubMed ID: 28523642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [THE EFFECT OF PLAKOPHILIN-2 GENE MUTATIONS ON ACTIVITY OF THE CANONICAL Wnt SIGNALING PATHWAY].
    Khudiakov AA; Kostina DA; Kostareva AA; Tomilin AN; Malashicheva AB
    Tsitologiia; 2015; 57(12):868-75. PubMed ID: 26995964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arrhythmogenic right ventricular cardiomyopathy mutations alter shear response without changes in cell-cell adhesion.
    Hariharan V; Asimaki A; Michaelson JE; Plovie E; MacRae CA; Saffitz JE; Huang H
    Cardiovasc Res; 2014 Nov; 104(2):280-9. PubMed ID: 25253076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AAV-Mediated Delivery of Plakophilin-2a Arrests Progression of Arrhythmogenic Right Ventricular Cardiomyopathy in Murine Hearts: Preclinical Evidence Supporting Gene Therapy in Humans.
    van Opbergen CJM; Narayanan B; Sacramento CB; Stiles KM; Mishra V; Frenk E; Ricks D; Chen G; Zhang M; Yarabe P; Schwartz J; Delmar M; Herzog CD; Cerrone M
    Circ Genom Precis Med; 2024 Feb; 17(1):e004305. PubMed ID: 38288614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of an arrhythmogenic right ventricular cardiomyopathy derived iPSC cell line (USFi004-A) carrying a heterozygous mutation in PKP2 (c.1799delA).
    Yang J; Samal E; Burgos Angulo M; Bertalovitz A; McDonald TV
    Stem Cell Res; 2021 Jul; 54():102398. PubMed ID: 34034221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unique genetic background and outcome of non-Caucasian Japanese probands with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Wada Y; Ohno S; Aiba T; Horie M
    Mol Genet Genomic Med; 2017 Nov; 5(6):639-651. PubMed ID: 29178656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.